ORBITAL TUMOURS-1
ORBITAL TUMOURS-1
ORBITAL TUMOURS-1
TUMOURS
DR PARTHA SARATHI GAYAN
ASSOCIATE PROFESSOR,RIO,GMCH
TYPES
PRIMARY TUMOUR
SECONDARY TUMOUR
METASTATIS TUMOUR
PRIMARY TUMOURS
◦ Those arising from various orbital structures
DERMOID
◦ SUPERFICIAL DERMOID-
Seen in infancy
Appears in the superotemporal or superonasal aspect of the orbit
Donot extend deep into the orbit and not associated with any bony defects
◦ DEEP DERMOID
Seen during adolescence
Proptosis or mass lesion having indistinct posterior margin(as arises from deeper structure)
May be associated with bony defects.
TREATMENT
SURGICAL EXCISION WITH COMPLETE REMOVAL OF CYST
EPIDERMOID
◦ Composed of epidermis without any epidermal appendages in the walls of the cyst
◦ Almost always CYSTIC
◦ Cyst wall consists of keratin debris.
◦ TREATMENT
SURGICAL EXCISION
LIPODERMOID
◦ SOLID TUMOURS seen beneath the conjunctiva
◦ Located adjacent to the superior temporal quadrant of the globe
TREATMENT
◦ CYSTIC TUMOUR-EXCISION
◦ SOLID TUMOUR-EXENTERATION
VASCULAR TUMOUR
◦ 1.CAPILLARY HEMANGIOMA
◦ Commonest at birth or during first month
◦ TREATMENT
◦ Indications of treatment-
Optic nerve compression
Exposure keratitis
Ocular dysfunction
Cosmetic blemish
Modes of therapy
TREATMENT
◦ SURGICAL EXCISION OF THE TUMOUR BY LATERAL ORBITOTOMY
LYMPHANGIOMA
◦ Uncommon tumour
◦ Slowly progressive proptosis in young adults
◦ ENLARGES SUDDENLY DUE TO SPONTANEOUS BLEED WITHIN THE VASCULAR
SPACES ,leading to the formation of the CHOCOLATE CYST.
◦ May regress spontaneously
MESENCHYMAL TUMOURS
◦RHABDOMYOSARCOMA
◦ highly malignant
◦Arises from pluripotent mesenchymal cells which can
differentiate into striated muscles
◦Most common primary orbital tumour in children
◦<15 years (90%)
◦More in males
RHABDOMYOSARCOMA
HISTOPATHOLOGY
◦ EMBRYONAL SARCOMA(60%)-MOST COMMON
◦ ALVEOLAR SARCOMA(31%)-MOST MALIGNANT
◦ BOTYROID(6%)
◦ SPINDLE CELLS(3%)
◦ ANAPLASTIC,ALSO KNOWN AS PLEOMORPHIC SARCOMA(LEAST COMMON)
CLINICAL FEATURES
◦ RAPID ONSET OF PROGRESSIVE PROPTOSIS IN A CHILD OF 7 TO 8 YEARS.
◦ CONFIRMATION BY BIOPSY
TREATMENT
◦ SURGICAL EXCISION
◦ CHEMOTHERAPY- VINCRISTINE 2mg/m2 ON DAY 1 AND DAY 5
- ACTINOMYCIN D 0.015 mg/kg iv once daily for 5 days
- CYCLOPHOSPHAMIDE 10mg/kg ONCE DAILY FOR FIRST 3 DAYS
THIS IS REPEATED EVERY 4 WEEKS FOR A PERIOD OF 2 YEARS
Good prognosis in embryonal but not in alveolar sarcomas
◦ RADIATION THERAPY(5000 RADS IN 5 WEEKS)
◦ EXENTERATION IN FEW UNRESPONSIVE CASES
IV. NEURAL TUMOURS
◦ OPTIC NERVE GLIOMA
Slow growing tumour arising from ASTROCYTES
Occurs in first decade of life
CLINICAL FEATURE
Gradual progressive painless loss of vision associated with unilateral AXIAL
PROPTOSIS
◦TREATMENT
◦ OBSERVATION
◦ SURGICAL EXCISION
◦ RADIOTHERAPY
MENINGIOMA
◦ INVASIVE TUMOUR ARISING FROM ARACHNOIDAL VILLI
◦ 2 TYPES:
1.PRIMARY INTRAORBITAL MENINGIOMA
Also known as optic nerve sheath meningioma
Early visual loss associated with limitation of ocular movements,optic disc edema or atrophy
and slowly progressive unilateral proptosis
OPTOCILIARY SHUNT is pathognomic
CT SCAN is DIAGNOSTIC
TREATMENT
Observation
Surgical excision
ORBITAL MENINGIOMA
◦ (b) Secondary orbital meningioma
INTRACRANIAL MENINGIOMA which secondarily involve ORBIT
Either arise from SPHENOID BONE
CLINICAL FEATURES
BOGGY EYELID SWELLING and ipsilateral swelling in the temporal region of the face
PROPTOSIS and lesser VISUAL IMPAIRMENT than primary orbital meningioma
TREATMENT
Observation
Subtotal resection through combined approach to intracranial and orbital component ,together with
NEUROSURGEON
Postoperative radiotherapy
V.LYMPHOPROLIFERATIVE
TUMOURS
WHO CONSENSUS CLASSIFICATION IS AS BELOW:
◦ BENIGN REATIVE LYMPHOID HYPERPLASIA
◦ MALIGNANT ORBITAL LYMPHOMA
◦ LANGERHANS CELL HISTIOCYTOSIS
BENIGN REACTIVE LYMPHOID HYPERPLASIA
◦ CLINICAL FEATURES
-PROPTOSIS
-FIRM RUBBERY MASS
-PINK SUBCONJUNCTIVAL INFILTRATE (SALMON PATCH)
TREATMENT
Systemic steroids and local radiotherapy
Cytotoxic drugs
ATYPICAL LYMPHOID
HYPERPLASIA
◦ It is intermediate between BENIGN REACTIVE LYMPHOID HYPERPLASIA and
MALIGNANT LYMPHOMA